BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34675884)

  • 21. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Serum Calcitonin Level and Ultrasonographic Characteristics Predict the Risk of Metastatic Medullary Thyroid Carcinoma: Functional Analysis of Calcitonin-Related Genes.
    Fan Y; Xu H; Lv M; Li N
    Dis Markers; 2022; 2022():9980185. PubMed ID: 35280443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    Zhu Q; Xu D
    BMC Cancer; 2021 Apr; 21(1):344. PubMed ID: 33794811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.
    Jiang K; Lei J; Chen W; Gong Y; Luo H; Li Z; Gong R; Zhu J
    Medicine (Baltimore); 2016 Oct; 95(40):e5079. PubMed ID: 27749581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
    Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
    Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
    Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
    De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
    Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
    He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
    [No Abstract]   [Full Text] [Related]  

  • 31. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
    Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]   [Full Text] [Related]  

  • 33. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
    Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
    [No Abstract]   [Full Text] [Related]  

  • 34. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
    Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
    World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
    Niederle MB; Scheuba C; Gessl A; Li S; Koperek O; Bieglmayer C; Riss P; Selberherr A; Niederle B
    Biochem Med (Zagreb); 2018 Oct; 28(3):030710. PubMed ID: 30429678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
    Kihara M; Miyauchi A; Kudo T; Hirokawa M; Miya A
    Endocr J; 2016 Jul; 63(7):627-32. PubMed ID: 27097651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
    Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.